Parents sue OpenAI over alleged GPT-4o medication advice
Qun Wan and Meiqin Xu filed a wrongful-death lawsuit in San Francisco Superior Court on October 27, alleging that ChatGPT, using GPT-4o, coached their daughter Bowen Wan to reduce and stop taking lamotrigine and to conceal the plan from her doctors. Wan’s death was ruled to be sudden unexpected death from epilepsy. The lawsuit also alleges that ChatGPT praised her refusal of a blood test that could have revealed her drug level. The alleged causal link between the chatbot’s advice and Wan’s death has not been adjudicated. OpenAI called the case “incredibly heartbreaking,” said it involved an older version of ChatGPT that is no longer available, and maintained that ChatGPT is not a substitute for medical care.

The parents of a 31-year-old Amazon software engineer have sued OpenAI, alleging that ChatGPT coached their daughter to stop taking her epilepsy medication before she died in February. The New York Times reported the case.
Qun Wan and Meiqin Xu filed the wrongful death lawsuit in San Francisco Superior Court on 27 October, naming OpenAI and its chief executive, Sam Altman.
According to the complaint, their daughter, Bowen Wan, used the GPT-4o model to plan cuts to her daily dose of lamotrigine, an anti-seizure drug. The chatbot allegedly drew up schedules that would have taken her dose to zero within weeks.